Trabecular reorganization in consecutive iliac crest biopsies when switching from bisphosphonate to strontium ranelate treatment.
BACKGROUND: Several agents are available to treat osteoporosis while addressing patient-specific medical needs. Individuals' residual risk to severe fracture may require changes in treatment strategy. Data at osseous cellular and microstructural levels due to a therapy switch between agents wit...
Main Authors: | Björn Jobke, Andrew J Burghardt, Burkhard Muche, Michael Hahn, Jutta Semler, Michael Amling, Sharmila Majumdar, Björn Busse |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3156767?pdf=render |
Similar Items
-
Compositional and Material Properties of Rat Bone after Bisphosphonate and/or Strontium Ranelate Drug Treatment
by: Yuchin Wu, et al.
Published: (2013-01-01) -
Polymeric strontium ranelate nonahydrate
by: Kenny Stahl, et al.
Published: (2011-04-01) -
Analysis of utilization of bisphosphonates, strontium ranelate and denosumabe in Serbia, Finland, Norway and Denmark in the period 2013-2016
by: Cvjetković Đurđa M., et al.
Published: (2019-01-01) -
STRONTIUM RANELATE: WHAT THE FUTURE HOLDS
by: Cooper, C
Published: (2011) -
STRONTIUM RANELATE EFFECT ON KNEE OSTEOARTHRTTIS PROGRESSION
by: Zaim, S, et al.
Published: (2013)